PCI Pharma Services is heading to Biotech Outsourcing Strategies CMC

PCI Pharma Services will exhibit at the upcoming event taking place 19–20 June at the Congress Centre, Basel

PCI Pharma Services will exhibit at the upcoming Biotech Outsourcing Strategies (BOS) CMC event taking place at the Congress Centre, Basel, 19-20 June. At the event PCI will offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch.

Its state of the art facilities and capability enable the safe development and manufacture of potent products with an OEL down to 0.01 μg/m3.

The comprehensive pharmaceutical development service, offered by PCI includes early stage formulation and analytical development, drug in capsule/vial using Xcelodose technology, scale-up and process validation, technology transfer and all associated analytical support services.

By involving PCI experts early in the strategic development of a new product, PCI can assist in optimising the process, ensure that regulatory hurdles are minimised and that the most efficient routes to clinic are delivered.

Companies